FRAT1: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Underlinked|date=May 2016}} | |||
{{ | {{Infobox_gene}} | ||
| | '''Proto-oncogene FRAT1''' is a [[protein]] that in humans is encoded by the ''FRAT1'' [[gene]].<ref name="pmid9034327">{{cite journal | vauthors = Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A | title = Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas | journal = EMBO J | volume = 16 | issue = 3 | pages = 441–50 |date=Mar 1997 | pmid = 9034327 | pmc = 1169648 | doi = 10.1093/emboj/16.3.441 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: FRAT1 frequently rearranged in advanced T-cell lymphomas| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10023| accessdate = }}</ref> | ||
}} | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = The protein encoded by this gene belongs to the GSK-3-binding protein family. It may function in tumor progression and in lymphomagenesis.<ref name="entrez" | | summary_text = The protein encoded by this gene belongs to the GSK-3-binding protein family. It may function in tumor progression and in lymphomagenesis.<ref name="entrez"/> | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal | vauthors=Li L, Yuan H, Weaver CD |title=Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. |journal=EMBO J. |volume=18 |issue= 15 |pages= 4233–40 |year= 1999 |pmid= 10428961 |doi= 10.1093/emboj/18.15.4233 | pmc=1171499 |display-authors=etal}} | ||
*{{cite journal | vauthors=Saitoh T, Katoh M |title=FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. |journal=Int. J. Oncol. |volume=19 |issue= 2 |pages= 311–5 |year= 2001 |pmid= 11445844 |doi= 10.3892/ijo.19.2.311}} | |||
*{{cite journal | | *{{cite journal | vauthors=Bax B, Carter PS, Lewis C |title=The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. |journal=Structure |volume=9 |issue= 12 |pages= 1143–52 |year= 2002 |pmid= 11738041 |doi=10.1016/S0969-2126(01)00679-7 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Saitoh T, Mine T, Katoh M |title=Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. |journal=Int. J. Oncol. |volume=20 |issue= 4 |pages= 785–9 |year= 2002 |pmid= 11894125 |doi= 10.3892/ijo.20.4.785}} | ||
*{{cite journal | | *{{cite journal | vauthors=Freemantle SJ, Portland HB, Ewings K |title=Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2. |journal=Gene |volume=291 |issue= 1-2 |pages= 17–27 |year= 2002 |pmid= 12095675 |doi=10.1016/S0378-1119(02)00594-2 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Hino S, Michiue T, Asashima M, Kikuchi A |title=Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin. |journal=J. Biol. Chem. |volume=278 |issue= 16 |pages= 14066–73 |year= 2003 |pmid= 12556519 |doi= 10.1074/jbc.M213265200 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Khambata-Ford S, Liu Y, Gleason C |title=Identification of promoter regions in the human genome by using a retroviral plasmid library-based functional reporter gene assay. |journal=Genome Res. |volume=13 |issue= 7 |pages= 1765–74 |year= 2003 |pmid= 12805274 |doi= 10.1101/gr.529803 | pmc=403750 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Deloukas P, Earthrowl ME, Grafham DV |title=The DNA sequence and comparative analysis of human chromosome 10. |journal=Nature |volume=429 |issue= 6990 |pages= 375–81 |year= 2004 |pmid= 15164054 |doi= 10.1038/nature02462 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Wang Y, Hewitt SM, Liu S |title=Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours. |journal=Br. J. Cancer |volume=94 |issue= 5 |pages= 686–91 |year= 2006 |pmid= 16479254 |doi= 10.1038/sj.bjc.6602988 | pmc=2361213 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Hagen T, Cross DA, Culbert AA |title=FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A. |journal=J. Biol. Chem. |volume=281 |issue= 46 |pages= 35021–9 |year= 2007 |pmid= 16982607 |doi= 10.1074/jbc.M607003200 |display-authors=etal}} | ||
*{{cite journal | | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{ | ==External links== | ||
{{ | * {{UCSC genome browser|FRAT1}} | ||
* {{UCSC gene details|FRAT1}} | |||
{{PDB Gallery|geneid=10023}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-10-stub}} |
Latest revision as of 04:56, 31 August 2017
This article needs more links to other articles to help integrate it into the encyclopedia. (May 2016) (Learn how and when to remove this template message) |
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Proto-oncogene FRAT1 is a protein that in humans is encoded by the FRAT1 gene.[1][2]
The protein encoded by this gene belongs to the GSK-3-binding protein family. It may function in tumor progression and in lymphomagenesis.[2]
References
- ↑ Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A (Mar 1997). "Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas". EMBO J. 16 (3): 441–50. doi:10.1093/emboj/16.3.441. PMC 1169648. PMID 9034327.
- ↑ 2.0 2.1 "Entrez Gene: FRAT1 frequently rearranged in advanced T-cell lymphomas".
Further reading
- Li L, Yuan H, Weaver CD, et al. (1999). "Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1". EMBO J. 18 (15): 4233–40. doi:10.1093/emboj/18.15.4233. PMC 1171499. PMID 10428961.
- Saitoh T, Katoh M (2001). "FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer". Int. J. Oncol. 19 (2): 311–5. doi:10.3892/ijo.19.2.311. PMID 11445844.
- Bax B, Carter PS, Lewis C, et al. (2002). "The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation". Structure. 9 (12): 1143–52. doi:10.1016/S0969-2126(01)00679-7. PMID 11738041.
- Saitoh T, Mine T, Katoh M (2002). "Molecular cloning and expression of proto-oncogene FRAT1 in human cancer". Int. J. Oncol. 20 (4): 785–9. doi:10.3892/ijo.20.4.785. PMID 11894125.
- Freemantle SJ, Portland HB, Ewings K, et al. (2002). "Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2". Gene. 291 (1–2): 17–27. doi:10.1016/S0378-1119(02)00594-2. PMID 12095675.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Hino S, Michiue T, Asashima M, Kikuchi A (2003). "Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin". J. Biol. Chem. 278 (16): 14066–73. doi:10.1074/jbc.M213265200. PMID 12556519.
- Khambata-Ford S, Liu Y, Gleason C, et al. (2003). "Identification of promoter regions in the human genome by using a retroviral plasmid library-based functional reporter gene assay". Genome Res. 13 (7): 1765–74. doi:10.1101/gr.529803. PMC 403750. PMID 12805274.
- Deloukas P, Earthrowl ME, Grafham DV, et al. (2004). "The DNA sequence and comparative analysis of human chromosome 10". Nature. 429 (6990): 375–81. doi:10.1038/nature02462. PMID 15164054.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Wang Y, Hewitt SM, Liu S, et al. (2006). "Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours". Br. J. Cancer. 94 (5): 686–91. doi:10.1038/sj.bjc.6602988. PMC 2361213. PMID 16479254.
- Hagen T, Cross DA, Culbert AA, et al. (2007). "FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A.". J. Biol. Chem. 281 (46): 35021–9. doi:10.1074/jbc.M607003200. PMID 16982607.
External links
- FRAT1 human gene location in the UCSC Genome Browser.
- FRAT1 human gene details in the UCSC Genome Browser.
This article on a gene on human chromosome 10 is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with broken file links
- Articles with too few wikilinks from May 2016
- Articles with invalid date parameter in template
- All articles with too few wikilinks
- Articles covered by WikiProject Wikify from May 2016
- All articles covered by WikiProject Wikify
- Genes on human chromosome
- All stub articles
- Human chromosome 10 gene stubs